Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

Overview of attention for article published in Seminars in Cancer Biology, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#34 of 1,449)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 5 news stories from 3 outlets.

Abstract Hsa_circ_0022383 (circ_0022383) is a newly discovered circRNA. Its functions and relevant molecular mechanisms in…

Abstract According to the latest epidemiological investigation, lung adenocarcinoma (LUAD) is one of the most fatal cancer…

Byline: Jin Jiao, Wen-wen Li, Yan-hong Shang, Xiao-fang Li and Meng Jiao KEYWORDS: Advanced NSCLC, Chemotherapy, Immunotherapy…

Abstract Background Inositol Polyphosphate-5-Phosphatase B (INPP5B), a inositol 5-phosphatase, plays an important role in many…

1. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas.